Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Effect of repetitive intra-arterial infusion of bone marrow mononuclear cells in patients with no-option limb ischemia: the randomized, double-blind, placebo-controlled Rejuvenating Endothelial Progenitor Cells via Transcutaneous Intra-arterial Supplementation (JUVENTAS) trial.
Teraa M, Sprengers RW, Schutgens RE, Slaper-Cortenbach IC, van der Graaf Y, Algra A, van der Tweel I, Doevendans PA, Mali WP, Moll FL, Verhaar MC. Teraa M, et al. Among authors: schutgens re. Circulation. 2015 Mar 10;131(10):851-60. doi: 10.1161/CIRCULATIONAHA.114.012913. Epub 2015 Jan 7. Circulation. 2015. PMID: 25567765 Clinical Trial.
Cardiovascular disease in patients with hemophilia.
Tuinenburg A, Mauser-Bunschoten EP, Verhaar MC, Biesma DH, Schutgens RE. Tuinenburg A, et al. Among authors: schutgens re. J Thromb Haemost. 2009 Feb;7(2):247-54. doi: 10.1111/j.1538-7836.2008.03201.x. Epub 2008 Oct 18. J Thromb Haemost. 2009. PMID: 18983484 Free article. Review.
Comment on 'Stem-cell therapy for peripheral arterial occlusive disease'.
Teraa M, Verhaar MC, Gremmels H, Fledderus JO, Schutgens RE, Moll FL. Teraa M, et al. Among authors: schutgens re. Eur J Vasc Endovasc Surg. 2012 Apr;43(4):486; author reply 487. doi: 10.1016/j.ejvs.2012.01.010. Epub 2012 Jan 28. Eur J Vasc Endovasc Surg. 2012. PMID: 22285067 Free article. No abstract available.
Apixaban versus Antiplatelet drugs or no antithrombotic drugs after anticoagulation-associated intraCerebral HaEmorrhage in patients with Atrial Fibrillation (APACHE-AF): study protocol for a randomised controlled trial.
van Nieuwenhuizen KM, van der Worp HB, Algra A, Kappelle LJ, Rinkel GJ, van Gelder IC, Schutgens RE, Klijn CJ; APACHE-AF Investigators. van Nieuwenhuizen KM, et al. Among authors: schutgens re. Trials. 2015 Sep 4;16:393. doi: 10.1186/s13063-015-0898-4. Trials. 2015. PMID: 26340977 Free PMC article. Clinical Trial.
Apixaban versus no anticoagulation after anticoagulation-associated intracerebral haemorrhage in patients with atrial fibrillation in the Netherlands (APACHE-AF): a randomised, open-label, phase 2 trial.
Schreuder FHBM, van Nieuwenhuizen KM, Hofmeijer J, Vermeer SE, Kerkhoff H, Zock E, Luijckx GJ, Messchendorp GP, van Tuijl J, Bienfait HP, Booij SJ, van den Wijngaard IR, Remmers MJM, Schreuder AHCML, Dippel DW, Staals J, Brouwers PJAM, Wermer MJH, Coutinho JM, Kwa VIH, van Gelder IC, Schutgens REG, Zweedijk B, Algra A, van Dalen JW, Jaap Kappelle L, Rinkel GJE, van der Worp HB, Klijn CJM; APACHE-AF Trial Investigators. Schreuder FHBM, et al. Lancet Neurol. 2021 Nov;20(11):907-916. doi: 10.1016/S1474-4422(21)00298-2. Lancet Neurol. 2021. PMID: 34687635
Proton pump inhibition for secondary hemochromatosis in hereditary anemia: a phase III placebo-controlled randomized cross-over clinical trial.
van Vuren A, Kerkhoffs JL, Schols S, Rijneveld A, Nur E, Peereboom D, Gandon Y, Welsing P, van Wijk R, Schutgens R, van Solinge W, Marx J, Leiner T, Biemond B, van Beers E. van Vuren A, et al. Am J Hematol. 2022 Jul;97(7):924-932. doi: 10.1002/ajh.26581. Epub 2022 May 10. Am J Hematol. 2022. PMID: 35472008 Free PMC article. Clinical Trial.
255 results